Find Amino Acids Mixture manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

FDF DossiersDRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Amino acids, essential, Amino acids, essential-, E500000000
Molecular Formula
C52H94N10O17S
Molecular Weight
1163.4  g/mol
InChI Key
CSARAUHTYFKILW-HGFMUWJKSA-N

Amino Acids Mixture
Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.
1 2D Structure

Amino Acids Mixture

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3R)-2-amino-3-hydroxybutanoic acid;(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S)-2-amino-3-methylbutanoic acid;(2S)-2-amino-4-methylpentanoic acid;(2S,3S)-2-amino-3-methylpentanoic acid;(2S)-2-amino-4-methylsulfanylbutanoic acid;(2S)-2-amino-3-phenylpropanoic acid;(2S)-2,6-diaminohexanoic acid
2.1.2 InChI
InChI=1S/C11H12N2O2.C9H11NO2.C6H14N2O2.2C6H13NO2.C5H11NO2S.C5H11NO2.C4H9NO3/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10;10-8(9(11)12)6-7-4-2-1-3-5-7;7-4-2-1-3-5(8)6(9)10;1-4(2)3-5(7)6(8)9;1-3-4(2)5(7)6(8)9;1-9-3-2-4(6)5(7)8;1-3(2)4(6)5(7)8;1-2(6)3(5)4(7)8/h1-4,6,9,13H,5,12H2,(H,14,15);1-5,8H,6,10H2,(H,11,12);5H,1-4,7-8H2,(H,9,10);2*4-5H,3,7H2,1-2H3,(H,8,9);4H,2-3,6H2,1H3,(H,7,8);3-4H,6H2,1-2H3,(H,7,8);2-3,6H,5H2,1H3,(H,7,8)/t9-;8-;2*5-;4-,5-;2*4-;2-,3+/m00000001/s1
2.1.3 InChI Key
CSARAUHTYFKILW-HGFMUWJKSA-N
2.1.4 Canonical SMILES
CCC(C)C(C(=O)O)N.CC(C)CC(C(=O)O)N.CC(C)C(C(=O)O)N.CC(C(C(=O)O)N)O.CSCCC(C(=O)O)N.C1=CC=C(C=C1)CC(C(=O)O)N.C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N.C(CCN)CC(C(=O)O)N
2.1.5 Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)O)N.C[C@H]([C@@H](C(=O)O)N)O.CC(C)C[C@@H](C(=O)O)N.CC(C)[C@@H](C(=O)O)N.CSCC[C@@H](C(=O)O)N.C1=CC=C(C=C1)C[C@@H](C(=O)O)N.C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N.C(CCN)C[C@@H](C(=O)O)N
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Acid, Essential Amino

2. Acids, Essential Amino

3. Amino Acid, Essential

4. Amino Acids, Essential

5. Essential Amino Acid

2.2.2 Depositor-Supplied Synonyms

1. Amino Acids, Essential

2. Amino Acids, Essential-

3. E500000000

2.3 Create Date
2012-03-21
3 Chemical and Physical Properties
Molecular Weight 1163.4 g/mol
Molecular Formula C52H94N10O17S
Hydrogen Bond Donor Count19
Hydrogen Bond Acceptor Count27
Rotatable Bond Count25
Exact Mass1162.65191274 g/mol
Monoisotopic Mass1162.65191274 g/mol
Topological Polar Surface Area594 Ų
Heavy Atom Count80
Formal Charge0
Complexity988
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count8

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Ajinomoto Co Inc

Japan

USDMF

arrow
The MedTech Conference
Not Confirmed

01

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-08-14

Pay. Date : 2018-07-02

DMF Number : 1076

Submission : 1967-08-15

Status : Active

Type : II

blank

02

The MedTech Conference
Not Confirmed

02

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3407

Submission : 1979-01-09

Status : Inactive

Type : II

blank

03

The MedTech Conference
Not Confirmed

03

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 2631

Submission : 1976-03-18

Status : Inactive

Type : II

blank

04

The MedTech Conference
Not Confirmed

04

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3223

Submission : 1978-06-16

Status : Inactive

Type : II

blank

05

The MedTech Conference
Not Confirmed

05

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-05

Pay. Date : 2013-01-25

DMF Number : 3149

Submission : 1978-03-15

Status : Active

Type : II

blank

06

The MedTech Conference
Not Confirmed

06

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3131

Submission : 1978-02-27

Status : Active

Type : II

blank

07

Tanabe Seiyaku Co Ltd

Japan

USDMF

arrow
The MedTech Conference
Not Confirmed

07

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4194

Submission : 1981-05-29

Status : Inactive

Type : II

blank

08

Tanabe Seiyaku Co Ltd

Japan

USDMF

arrow
The MedTech Conference
Not Confirmed

08

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 1990

Submission : 1972-09-01

Status : Inactive

Type : II

blank

09

Tanabe Seiyaku Co Ltd

Japan

USDMF

arrow
The MedTech Conference
Not Confirmed

09

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4259

Submission : 1981-07-24

Status : Inactive

Type : II

blank

10

Tanabe Seiyaku Co Ltd

Japan

USDMF

arrow
The MedTech Conference
Not Confirmed

10

The MedTech Conference
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4202

Submission : 1981-05-29

Status : Inactive

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; ORNITHINE HYDROCHLORIDE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE

NDC Package Code : 51495-205

Start Marketing Date : 2022-10-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (7.8kg/100kg 8.2kg/100kg 5.85kg/100kg 1.85kg/100kg 9.75kg/100kg 3.92kg/100kg 3.72kg/100kg 6.5kg/100kg 9.75kg/100kg 12.05kg/100kg 2.35kg/100kg 3.1kg/100kg 4.12kg/100kg 2.94kg/100kg 3.92kg/100kg .59kg/100kg 3.62kg/100kg 1.97kg/100kg .76kg/100kg 7.4kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE

NDC Package Code : 51495-203

Start Marketing Date : 2022-10-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (8.5kg/100kg 9.55kg/100kg 4.56kg/100kg 6.4kg/100kg 7.6kg/100kg 9.1kg/100kg 8.5kg/100kg 7.6kg/100kg 5.1kg/100kg 5.3kg/100kg 4.56kg/100kg 5.75kg/100kg 2.42kg/100kg 2.69kg/100kg 12.45kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE

NDC Package Code : 51495-199

Start Marketing Date : 2022-10-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (14.01kg/100kg 9.49kg/100kg 2.8kg/100kg 4.84kg/100kg 6.72kg/100kg 5.77kg/100kg 4.84kg/100kg 6.72kg/100kg 10.75kg/100kg 4.84kg/100kg 6.72kg/100kg 5.77kg/100kg 3.82kg/100kg 4.84kg/100kg 1.61kg/100kg .252kg/100kg 6.2kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PROLINE; SERINE; THREONINE; TYROSINE; VALINE

NDC Package Code : 51495-178

Start Marketing Date : 2022-10-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (22.01kg/100kg 12.23kg/100kg 10.95kg/100kg 5.1kg/100kg 6.38kg/100kg 7.76kg/100kg 7.71kg/100kg 4.25kg/100kg 7.23kg/100kg 5.32kg/100kg 4.47kg/100kg .43kg/100kg 6.17kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE

NDC Package Code : 51495-201

Start Marketing Date : 2022-10-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (20.41kg/100kg 11.34kg/100kg 10.15kg/100kg 4.73kg/100kg 5.91kg/100kg 7.2kg/100kg 7.15kg/100kg 3.94kg/100kg 5.52kg/100kg 6.7kg/100kg 4.93kg/100kg 4.14kg/100kg 1.77kg/100kg .39kg/100kg 5.72kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

About the Company : Yichang Three Gorges Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Renfu Pharmaceutical Group, is a national high-tech biopharmaceutical enterprise specializing in antibio...

Yichang Three Gorges Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Renfu Pharmaceutical Group, is a national high-tech biopharmaceutical enterprise specializing in antibiotic APIs, high-capacity amino acid injections, and veterinary drug formulations. Recognized as a "Hidden Champion Technology Little Giant" in Hubei's key industries, the company has received accolades such as "Excellent Export Enterprise for Pharmaceutical Raw Materials" and "Top 10 Exporters for Foreign Exchange Earnings" in Hubei. Its "Three Gorges Brand" is a well-known trademark in Yichang.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Amino acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.


Lead Product(s): Amino Acids Mixture,Inapplicable

Therapeutic Area: Endocrinology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Chengdu Qingshan Likang Pharmaceutical

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 22, 2025

blank

01

The People's Hospital of Gaozhou

Country
arrow
The MedTech Conference
Not Confirmed

The People's Hospital of Gaozhou

Country
arrow
The MedTech Conference
Not Confirmed

Lead Product(s) : Amino Acids Mixture,Inapplicable

Therapeutic Area : Endocrinology

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Chengdu Qingshan Likang Pharmaceutical

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Amino acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 22, 2025

blank
  • Development Update

Details:

Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Parkinson Disease.


Lead Product(s): Amino Acids Mixture,Inapplicable

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 01, 2025

blank

02

UConn Health

Country
arrow
The MedTech Conference
Not Confirmed

UConn Health

Country
arrow
The MedTech Conference
Not Confirmed

Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Parkinson Disease.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 01, 2025

blank
  • Development Update

Details:

Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Kidney Failure, Chronic.


Lead Product(s): Amino Acids Mixture,Inapplicable

Therapeutic Area: Nephrology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 19, 2024

blank

03

Chengdu Qingshan Likang Pharmaceutical

Country
arrow
The MedTech Conference
Not Confirmed

Chengdu Qingshan Likang Pharmaceutical

Country
arrow
The MedTech Conference
Not Confirmed

Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Kidney Failure, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 19, 2024

blank

Details:

177-Lu Edotreotide is a Radiolabeled Compounds drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neuroendocrine Tumors.


Lead Product(s): 177-Lu Edotreotide,Amino Acids Mixture

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Radiolabeled Compound

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 04, 2024

blank

04

The MedTech Conference
Not Confirmed
The MedTech Conference
Not Confirmed

Details : 177-Lu Edotreotide is a Radiolabeled Compounds drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neuroendocrine Tumors.

Product Name : Undisclosed

Product Type : Radiolabeled Compound

Upfront Cash : Inapplicable

June 04, 2024

blank

Details:

NuGenea is a nutraceutical formulated with 20 different ingredients which have been scientifically shown to help fight chronic inflammation, which is a causative factor in illnesses such as cancer, diabetes, COPD and heart disease.


Lead Product(s): Amino Acids Mixture,Inapplicable

Therapeutic Area: Immunology Brand Name: NuGenea

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 25, 2023

blank

05

The MedTech Conference
Not Confirmed
The MedTech Conference
Not Confirmed

Details : NuGenea is a nutraceutical formulated with 20 different ingredients which have been scientifically shown to help fight chronic inflammation, which is a causative factor in illnesses such as cancer, diabetes, COPD and heart disease.

Product Name : NuGenea

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 25, 2023

blank
  • Development Update

Details:

Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.


Lead Product(s): Amino Acids Mixture,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: KGK Science

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 31, 2022

blank

06

ZandA Technologies, llc

Country
arrow
The MedTech Conference
Not Confirmed

ZandA Technologies, llc

Country
arrow
The MedTech Conference
Not Confirmed

Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 31, 2022

blank

Details:

PKU GOLIKE® - a next generation medical phenylalanine-free food product engineered with the patent protected, pharmaceutical grade Physiomimic™ technology for the dietary management of phenylketonuria (PKU).


Lead Product(s): Amino Acids Mixture,Inapplicable

Therapeutic Area: Genetic Disease Brand Name: PKU GOLIKE

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 10, 2022

blank

07

Relief Therapeutics

Switzerland
arrow
The MedTech Conference
Not Confirmed

Relief Therapeutics

Switzerland
arrow
The MedTech Conference
Not Confirmed

Details : PKU GOLIKE® - a next generation medical phenylalanine-free food product engineered with the patent protected, pharmaceutical grade Physiomimic™ technology for the dietary management of phenylketonuria (PKU).

Product Name : PKU GOLIKE

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 10, 2022

blank

Details:

177-Lu DOTA-EB-TATE is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neuroendocrine Tumors.


Lead Product(s): 177-Lu DOTA-EB-TATE,Amino Acids Mixture

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: ClinSmart

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 26, 2022

blank

08

The MedTech Conference
Not Confirmed
The MedTech Conference
Not Confirmed

Details : 177-Lu DOTA-EB-TATE is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Neuroendocrine Tumors.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 26, 2022

blank
  • Development Update

Details:

Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Gastroenteritis.


Lead Product(s): Amino Acids Mixture,Electrolyte

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 21, 2022

blank

09

Mead Johnson Nutrition

Country
arrow
The MedTech Conference
Not Confirmed

Mead Johnson Nutrition

Country
arrow
The MedTech Conference
Not Confirmed

Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Gastroenteritis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 21, 2022

blank

Details:

Acquisition further diversifies Relief's pipeline with both commercial products and clinical-stage programs and provides a commercial infrastructure foundation for future product launches.


Lead Product(s): Amino Acids Mixture,Minerals,Undisclosed

Therapeutic Area: Genetic Disease Brand Name: PKU Golike

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Relief Therapeutics

Deal Size: $72.2 million Upfront Cash: $23.3 million

Deal Type: Acquisition June 29, 2021

blank

10

The MedTech Conference
Not Confirmed
The MedTech Conference
Not Confirmed

Details : Acquisition further diversifies Relief's pipeline with both commercial products and clinical-stage programs and provides a commercial infrastructure foundation for future product launches.

Product Name : PKU Golike

Product Type : Miscellaneous

Upfront Cash : $23.3 million

June 29, 2021

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

PMC Isochem

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

CAS Number : 5267-64-1

End Use API : Amino Acids Mixture

About The Company : PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipi...

PMC Isochem

02

The MedTech Conference
Not Confirmed
arrow
The MedTech Conference
Not Confirmed
arrow

CAS Number : 1149-26-4

End Use API : Amino Acids Mixture

About The Company : Zhejiang Hisoar Pharmaceutical Co., Ltd. is located in Taizhou, Zhejiang. It is an IPO-listed company held by the DanKong Group, which mainly manufactures APIs,...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

BAXTER SpA

Germany
The MedTech Conference
Not Confirmed
arrow

BAXTER SpA

Germany
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Tph

Dosage Form :

Dosage Strength : 1 Bottle Ev 100 Ml 6%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

BAXTER SpA

Germany
The MedTech Conference
Not Confirmed
arrow

BAXTER SpA

Germany
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Nutrineal Pd4

Dosage Form : Amino Acids 1,1% 2.000Ml 1 Units Parenteral Use

Dosage Strength : 1 bag 2,000 ml 1,1%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Siframin

Dosage Form :

Dosage Strength : 1 Bottle 500 Ml 4%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Strong Solamin

Dosage Form :

Dosage Strength : 1 Bottle Ev 250 Ml 7.5%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Vamin 14 g N/L Elektrolyttfri

Dosage Form : Infusion fluid, resolution

Dosage Strength : (not entered)

Packaging : The infusion bottle of glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Vaminolac

Dosage Form : Infusion fluid, resolution

Dosage Strength : (not entered)

Packaging : The infusion bottle of glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Isoleucine; Leucine; Lysine Anhydrous; Methionine; Phenylalanine; Threonine; Tryptophan; Valine; Arginine; Histidine; Alanine; Glycine; Proline; Serine; Tyrosine; Taurine; Amino Acids

Brand Name : Aminoven

Dosage Form : Infusion Solution

Dosage Strength :

Packaging :

Approval Date : 19/04/2000

Application Number : 55337

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Essential Amino Acids

Dosage Form :

Dosage Strength : 1 Bottle 250 Ml 5,3%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

BIEFFE MEDITAL SpA

Country
The MedTech Conference
Not Confirmed
arrow

BIEFFE MEDITAL SpA

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Isogrow 6%

Dosage Form :

Dosage Strength : 1 Bottle 500 Ml 6%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

BIEFFE MEDITAL SpA

Country
The MedTech Conference
Not Confirmed
arrow

BIEFFE MEDITAL SpA

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Isopuramin 3%

Dosage Form :

Dosage Strength : 1 Bottle Ev 500 Ml 3%  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

read-more
read-more

01

Amino Acids

Brand Name : Minamino

Dosage Form : SYR

Dosage Strength : 100mg/5ml

Packaging : 200X1mg/5ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

02

Amino Acids

Brand Name : Minamino

Dosage Form : SYR

Dosage Strength : 100mg/5ml

Packaging : 500X1mg/5ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

03

Adcock Ingram Limited

South Africa
The MedTech Conference
Not Confirmed
arrow

Adcock Ingram Limited

South Africa
arrow
The MedTech Conference
Not Confirmed

Amino Acids

Brand Name : TRIOMEL N7-960E

Dosage Form : INF

Dosage Strength : 40g/1000ml

Packaging : 2000X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

04

Adcock Ingram Limited

South Africa
The MedTech Conference
Not Confirmed
arrow

Adcock Ingram Limited

South Africa
arrow
The MedTech Conference
Not Confirmed

Amino Acids

Brand Name : TRIOMEL N9-840 E

Dosage Form : INF

Dosage Strength : 40g/1000ml

Packaging : 1500X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

05

Adcock Ingram Limited

South Africa
The MedTech Conference
Not Confirmed
arrow

Adcock Ingram Limited

South Africa
arrow
The MedTech Conference
Not Confirmed

Amino Acids

Brand Name : TRIOMEL N9-840

Dosage Form : INF

Dosage Strength : 40g/1000ml

Packaging : 1000X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

06

Adcock Ingram Limited

South Africa
The MedTech Conference
Not Confirmed
arrow

Adcock Ingram Limited

South Africa
arrow
The MedTech Conference
Not Confirmed

Amino Acids

Brand Name : TRIOMEL N4-600E

Dosage Form : INF

Dosage Strength : 30g/1000ml

Packaging : 2000X1g/1000ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino acids

Brand Name : ITN 3002 A

Dosage Form : INF

Dosage Strength : 1ZZZ

Packaging : 1X1ZZZ

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino acids

Brand Name : ITN 3019 A

Dosage Form : INF

Dosage Strength : 1ZZZ

Packaging : 1X1ZZZ

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino acids

Brand Name : ITN 7010 A

Dosage Form : INF

Dosage Strength : 1ZZZ

Packaging : 1X1ZZZ

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids

Brand Name : Glamin

Dosage Form : INF

Dosage Strength : 134g

Packaging : 1000X1g

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Brand Name : Supportamin Infusion

Dosage Form : Infusion

Dosage Strength : 8.5%

Packaging : Bag (100mL, 250mL)

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Amino Acids, Essential

Dosage : Infusion

Dosage Strength : 8.5%

Brand Name : Supportamin Infusion

Approval Date :

Application Number :

Registration Country : South Korea

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ferrous Ascorbate; Folic Acid; Vitamin B6; Zinc; Mecobalamin; AMINO ACIDS

Brand Name : Nicefer

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ferrous Ascorbate; Folic Acid; Vitamin B6; Zinc; Mecobalamin; AMINO ACIDS

Dosage : Tablet

Dosage Strength :

Brand Name : Nicefer

Approval Date :

Application Number :

Registration Country : India

blank

03

Vian

Greece
The MedTech Conference
Not Confirmed
arrow

Vian

Greece
arrow
The MedTech Conference
Not Confirmed

AMINO ACIDS; Vitamin B12

Brand Name : TONOTIL ®

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

blank

03

Vian

Greece
The MedTech Conference
Not Confirmed
arrow

Vian

Greece
arrow
The MedTech Conference
Not Confirmed

AMINO ACIDS; Vitamin B12

Dosage :

Dosage Strength :

Brand Name : TONOTIL ®

Approval Date :

Application Number :

Registration Country : Greece

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - 10% (10GM/100...DOSAGE - INJECTABLE;INJECTION - 10% (10GM/100ML)

USFDA APPLICATION NUMBER - 19018

read-more

DOSAGE - INJECTABLE;INJECTION - 6% (6GM/100ML...DOSAGE - INJECTABLE;INJECTION - 6% (6GM/100ML)

USFDA APPLICATION NUMBER - 19018

read-more

DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)

USFDA APPLICATION NUMBER - 200656

read-more

DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)

USFDA APPLICATION NUMBER - 200656

read-more

DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)

USFDA APPLICATION NUMBER - 200656

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)

USFDA APPLICATION NUMBER - 200656

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)

USFDA APPLICATION NUMBER - 200656

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)

USFDA APPLICATION NUMBER - 200656

read-more

DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)

USFDA APPLICATION NUMBER - 200656

read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Regulatory FDF Prices

read-more
read-more

01

Brand Name : Tph

Germany
arrow
The MedTech Conference
Not Confirmed

Brand Name : Tph

Germany
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 500 Ml 6%  

Price Per Pack (Euro) : 15.48

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

02

Brand Name : Tph

Germany
arrow
The MedTech Conference
Not Confirmed

Brand Name : Tph

Germany
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 250 Ml 6%  

Price Per Pack (Euro) : 11.7

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

03

Brand Name : Tph

Germany
arrow
The MedTech Conference
Not Confirmed

Brand Name : Tph

Germany
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 100 Ml 6%  

Price Per Pack (Euro) : 10.49

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

04

Brand Name : Isogrow 6%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isogrow 6%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle 500 Ml 6%  

Price Per Pack (Euro) : 10.32

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

05

Brand Name : Isogrow 6%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isogrow 6%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle 250 Ml 6%  

Price Per Pack (Euro) : 6.43

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

06

Brand Name : Isopuramin 10%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isopuramin 10%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 500 Ml 10%  

Price Per Pack (Euro) : 12.75

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

07

Brand Name : Isopuramin 10%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isopuramin 10%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 250 Ml 10%  

Price Per Pack (Euro) : 8.48

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

08

Brand Name : Isopuramin 3%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isopuramin 3%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 500 Ml 3%  

Price Per Pack (Euro) : 7.11

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

09

Brand Name : Isopuramin 3%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isopuramin 3%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 250 Ml 3%  

Price Per Pack (Euro) : 5.11

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank

10

Brand Name : Isopuramin 7%

Country
arrow
The MedTech Conference
Not Confirmed

Brand Name : Isopuramin 7%

Country
arrow
The MedTech Conference
Not Confirmed

Amino Acids Mixture

Dosage Form :

Dosage Strength : 1 Bottle Ev 500 Ml 7%  

Price Per Pack (Euro) : 10.43

Published in :

Country : Italy

RX/OTC/DISCN : Class C

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for / Amino Acids Mixture API manufacturers, exporters & distributors?

Amino Acids Mixture manufacturers, exporters & distributors 1

16

PharmaCompass offers a list of Amino Acids Mixture API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amino Acids Mixture manufacturer or Amino Acids Mixture supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amino Acids Mixture manufacturer or Amino Acids Mixture supplier.

PharmaCompass also assists you with knowing the Amino Acids Mixture API Price utilized in the formulation of products. Amino Acids Mixture API Price is not always fixed or binding as the Amino Acids Mixture Price is obtained through a variety of data sources. The Amino Acids Mixture Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Amino Acids Mixture

Synonyms

Amino acids, essential, Amino acids, essential-, E500000000

About Amino Acids Mixture

Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.

FREAMINE III 8.5% Manufacturers

A FREAMINE III 8.5% manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FREAMINE III 8.5%, including repackagers and relabelers. The FDA regulates FREAMINE III 8.5% manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FREAMINE III 8.5% API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of FREAMINE III 8.5% manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

FREAMINE III 8.5% Suppliers

A FREAMINE III 8.5% supplier is an individual or a company that provides FREAMINE III 8.5% active pharmaceutical ingredient (API) or FREAMINE III 8.5% finished formulations upon request. The FREAMINE III 8.5% suppliers may include FREAMINE III 8.5% API manufacturers, exporters, distributors and traders.

click here to find a list of FREAMINE III 8.5% suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

FREAMINE III 8.5% USDMF

A FREAMINE III 8.5% DMF (Drug Master File) is a document detailing the whole manufacturing process of FREAMINE III 8.5% active pharmaceutical ingredient (API) in detail. Different forms of FREAMINE III 8.5% DMFs exist exist since differing nations have different regulations, such as FREAMINE III 8.5% USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A FREAMINE III 8.5% DMF submitted to regulatory agencies in the US is known as a USDMF. FREAMINE III 8.5% USDMF includes data on FREAMINE III 8.5%'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FREAMINE III 8.5% USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of FREAMINE III 8.5% suppliers with USDMF on PharmaCompass.

FREAMINE III 8.5% CEP

A FREAMINE III 8.5% CEP of the European Pharmacopoeia monograph is often referred to as a FREAMINE III 8.5% Certificate of Suitability (COS). The purpose of a FREAMINE III 8.5% CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of FREAMINE III 8.5% EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of FREAMINE III 8.5% to their clients by showing that a FREAMINE III 8.5% CEP has been issued for it. The manufacturer submits a FREAMINE III 8.5% CEP (COS) as part of the market authorization procedure, and it takes on the role of a FREAMINE III 8.5% CEP holder for the record. Additionally, the data presented in the FREAMINE III 8.5% CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the FREAMINE III 8.5% DMF.

A FREAMINE III 8.5% CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. FREAMINE III 8.5% CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of FREAMINE III 8.5% suppliers with CEP (COS) on PharmaCompass.

FREAMINE III 8.5% NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FREAMINE III 8.5% as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for FREAMINE III 8.5% API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture FREAMINE III 8.5% as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain FREAMINE III 8.5% and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FREAMINE III 8.5% NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of FREAMINE III 8.5% suppliers with NDC on PharmaCompass.

FREAMINE III 8.5% GMP

FREAMINE III 8.5% Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of FREAMINE III 8.5% GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FREAMINE III 8.5% GMP manufacturer or FREAMINE III 8.5% GMP API supplier for your needs.

FREAMINE III 8.5% CoA

A FREAMINE III 8.5% CoA (Certificate of Analysis) is a formal document that attests to FREAMINE III 8.5%'s compliance with FREAMINE III 8.5% specifications and serves as a tool for batch-level quality control.

FREAMINE III 8.5% CoA mostly includes findings from lab analyses of a specific batch. For each FREAMINE III 8.5% CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

FREAMINE III 8.5% may be tested according to a variety of international standards, such as European Pharmacopoeia (FREAMINE III 8.5% EP), FREAMINE III 8.5% JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FREAMINE III 8.5% USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty